Gufic BioSciences Ltd logo

Gufic BioSciences Ltd

GUFICBIO NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹4,315 Cr
Volatility
Moderate
P/E Ratio
57.6
EBITDA
₹151 Cr
Return on Equity
11.59%
Debt to Equity
0.61
Book Value
₹66.31
EPS
₹8.59
52W High
₹448
52W Low
₹268

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Gufic BioSciences Ltd insights

49 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Weaknesses

3
  • Stock is trading at 6.37 times its book value
  • Company has a low return on equity of 13.5% over last 3 years.
  • Dividend payout has been low at 1.40% of profits over last 3 years

Growth Rate

Revenue Growth
14.65% ↗
Net Income Growth
4.67% ↘
Cash Flow Change
1743.03% ↗
ROE
-28.32% ↘
ROCE
-16.55% ↘
EBITDA Margin (Avg.)
-5.77% ↘

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
195
215
202
195
203
204
208
205
227
230
231
252
261
Expenses
160
176
165
161
167
166
174
178
195
195
195
206
214
Operating Profit
35
39
36
34
36
39
34
27
32
36
36
46
47
OPM %
18%
18%
18%
18%
18%
19%
16%
13%
14%
16%
16%
18%
18%
Other Income
1
0
0
1
1
0
2
0
1
2
1
-1
0
Interest
4
4
3
4
5
5
5
8
9
10
8
9
9
Depreciation
4
4
4
4
4
4
5
8
8
8
8
8
8
PBT
28
31
30
27
28
29
26
11
16
21
21
28
30
Tax %
26%
25%
25%
26%
26%
26%
26%
26%
26%
27%
26%
26%
26%
Net Profit
21
23
22
20
21
22
19
8
12
15
16
21
22
EPS in Rs
2.13
2.39
2.22
2
2.08
2.17
1.93
0.79
1.2
1.49
1.55
2.05
2.24
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
148
201
245
306
351
379
488
779
691
807
820
940
974
Expenses
134
181
222
267
305
327
404
631
556
657
683
790
810
Operating Profit
14
20
23
39
46
52
84
148
135
150
136
150
165
OPM %
10%
10%
9%
13%
13%
14%
17%
19%
20%
19%
17%
16%
17%
Other Income
1
1
1
4
4
6
4
3
3
0
4
3
2
Interest
4
6
6
9
10
14
14
5
8
17
25
37
37
Depreciation
4
4
4
4
5
14
16
19
22
17
21
31
31
PBT
7
10
14
30
35
30
58
127
107
116
94
85
99
Tax %
36%
29%
37%
45%
38%
25%
23%
24%
25%
26%
26%
26%
—
Net Profit
4
7
9
16
22
23
44
96
80
86
70
63
74
EPS in Rs
0.54
0.95
1.17
2.13
2.82
2.92
5.68
9.89
8.22
8.59
6.97
6.3
7.33
Div. Payout %
9%
5%
4%
2%
2%
2%
2%
1%
1%
1%
1%
2%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
8
8
8
10
10
10
10
10
10
10
Reserves
19
26
30
46
68
120
164
259
338
523
591
654
Borrowings
33
43
57
80
98
126
62
64
334
333
336
405
Other Liabilities
67
75
84
104
106
152
157
188
179
227
232
273
Total Liabilities
127
152
178
238
280
408
392
521
861
1,093
1,170
1,342
Fixed Assets
25
22
22
23
24
83
100
115
160
159
506
491
CWIP
0
0
0
2
10
31
13
41
170
307
22
22
Investments
0
0
0
0
0
0
0
0
1
2
3
3
Other Assets
102
130
156
213
245
294
279
365
531
625
639
826
Total Assets
127
152
178
238
280
408
392
521
861
1,093
1,170
1,342
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
11
-4
-4
-5
5
47
87
106
-27
-7
123
44
Investing
-2
-1
-5
-9
-13
-43
-7
-95
-191
-102
-72
-31
Financing
-5
5
7
14
8
-4
-79
-6
234
82
-37
32
Net Cash Flow
4
0
-1
1
0
0
2
5
17
-27
14
45
Free Cash Flow
9
-5
-8
-13
-8
7
75
19
-214
-116
52
13
CFO/OP
92
-8
2
30
33
110
115
94
1
13
107
37
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82
102
78
97
107
103
93
71
109
149
140
115
Inventory Days
165
180
190
238
190
249
138
102
202
188
211
281
Days Payable
223
188
132
192
157
238
162
125
143
156
155
173
Cash Conversion Cycle
25
94
136
143
141
114
69
48
167
181
197
224
Working Capital Days
4
18
14
26
40
17
63
50
68
97
93
81
ROCE %
18%
24%
24%
33%
30%
21%
29%
46%
23%
17%
13%
12%

Shareholding Pattern

As of Jun 2026
Promoters 72.50%
Public 14.00%
Others 9.36%
DIIs 3.68%
FIIs 0.46%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Oct 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
65.75%
65.13%
75.48%
75.48%
75.48%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
72.51%
72.51%
72.51%
72.51%
72.51%
72.51%
72.51%
72.51%
72.50%
72.50%
72.50%
72.50%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.72%
0.00%
0.12%
0.23%
0.24%
0.30%
0.31%
0.32%
0.34%
0.44%
0.42%
0.46%
DIIs
8.25%
3.24%
2.13%
1.19%
1.03%
1.03%
1.16%
1.16%
1.16%
1.16%
1.50%
1.58%
1.60%
2.20%
2.39%
2.51%
2.98%
3.39%
3.38%
3.65%
3.74%
3.83%
3.68%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
21.92%
27.67%
17.00%
17.40%
17.65%
17.84%
18.29%
18.24%
17.83%
17.84%
17.16%
16.66%
16.85%
16.72%
16.36%
16.01%
15.44%
15.15%
15.10%
14.45%
14.13%
13.93%
14.00%
Others
4.08%
3.95%
5.39%
5.94%
5.84%
6.13%
5.55%
5.60%
6.01%
6.00%
6.34%
8.53%
9.04%
8.45%
8.52%
8.73%
8.76%
8.64%
8.70%
9.06%
9.19%
9.31%
9.36%
No. of Shareholders
19,639
45,602
35,135
34,580
38,144
40,120
41,376
40,562
38,902
38,624
36,557
36,524
34,424
34,695
32,250
32,825
33,299
31,844
31,876
31,420
30,362
29,223
29,753

Documents

Frequently Asked Questions about Gufic BioSciences Ltd

What does Gufic BioSciences Ltd do?
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
Where is Gufic BioSciences Ltd (GUFICBIO) listed?
Gufic BioSciences Ltd is listed on the Indian stock exchanges. It is listed on NSE: GUFICBIO and BSE: 509079. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Gufic BioSciences Ltd belong to?
Gufic BioSciences Ltd operates in the Healthcare sector within the Pharmaceuticals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Gufic BioSciences Ltd?
Gufic BioSciences Ltd has a market capitalisation of approximately ₹4315.16 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Gufic BioSciences Ltd?
The Price-to-Earnings (PE) ratio of Gufic BioSciences Ltd is 57.60. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Gufic BioSciences Ltd?
Over the past 52 weeks, Gufic BioSciences Ltd has traded between a low of ₹268 and a high of ₹448. This range helps investors understand the stock's price volatility and recent trading levels.
Does Gufic BioSciences Ltd pay dividends?
Yes, Gufic BioSciences Ltd has a dividend yield of 0.02%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Gufic BioSciences Ltd?
Gufic BioSciences Ltd has a Return on Equity (ROE) of 11.59%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Gufic BioSciences Ltd on Tapetide?
On Tapetide, you can view Gufic BioSciences Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.

Website gufic.com
CEO Mr. Jayesh Pannalal Choksi
Employees 1,484
Listed 2004-10-19
Face Value ₹ 1
Issued Size 10,02,82,506

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List